Singapore, May 26 -- The Health Sciences Authority received information related to the study titled 'N-Acetylcysteine or Erdosteine for Exacerbations of Chronic Obstructive Pulmonary Disease (NEX COPD): A Feasibility Study'. The following are the other relevant details related to the trial:
Therapeutic Area: Respiratory
Trial Centre(s):
Changi General Hospital
Trial Status: NA
Principal Investigator(s):
Dr Isaac Fong
Published by HT Digital Content Services with permission from Health Daily Digest....